Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17939
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLee, Wei-I-
dc.contributor.authorCarney, Patrick W-
dc.contributor.authorHughes, Andrew J-
dc.contributor.authorArcher, John S-
dc.date2017-04-10-
dc.date.accessioned2018-06-21T05:42:08Z-
dc.date.available2018-06-21T05:42:08Z-
dc.date.issued2017-07-
dc.identifier.citationEpilepsy research 2017; 133: 93-97-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/17939-
dc.description.abstractPatients with recurrent focal motor seizures present a management dilemma, as anti-convulsants are often ineffective, and resective surgery poses a high risk of motor deficit. We describe three patients with recurrent focal motor seizures that remained refractory despite numerous anti-convulsant trials. All patients showed either hyperperfusion on Single-Photon Emission Computerised Tomography (SPECT) or hypermetabolism on Positron Emission Tomography (PET) in primary motor cortex during periods of sustained jerking, although EEG abnormalities were uncommon. After botulinum toxin (BoT) injection there was a rapid and dramatic reduction in seizure frequency in all patients despite minimal limb weakness. Seizure freedom persisted for 3-6 months following treatment in the injected area. Repeat BoT injections following seizure recurrence were again efficacious in one case. Combining data from our cases with those previously reported, it appears that BoT may be a useful therapeutic tool for recurrent focal motor seizures. We hypothesise that the toxin disrupts or down-regulates an epileptic circuit between motor cortex and muscle, in which volleys of information from muscle spindles have been perpetuating seizure discharges in the cortex.-
dc.language.isoeng-
dc.subjectBotox-
dc.subjectEPC-
dc.subjectEpilepsy network-
dc.subjectEpilepsy partialis continua-
dc.subjectStatus-
dc.titleRefractory focal motor seizures controlled with intramuscular botulinum toxin.-
dc.typeJournal Article-
dc.identifier.journaltitleEpilepsy research-
dc.identifier.affiliationDepartment of Neurology, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationDepartment of Neurology, Box Hill Hospital, Box Hill, Melbourne, Australia-
dc.identifier.affiliationThe University of Melbourne, Australia-
dc.identifier.doi10.1016/j.eplepsyres.2017.04.009-
dc.identifier.pubmedid28475998-
dc.type.austinCase Reports-
dc.type.austinJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
crisitem.author.deptNeurology-
crisitem.author.deptNeurology-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Feb 2, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.